Michael Markels Jr., VP, Commercial Operations and Business Development at NeurogesX Inc (NGSX), bought 96 shares at $1.50 ($144) on 2008-12-09, disclosed to the SEC on 2008-12-11.
Open-market purchase of $144 NGSX by VP, Commercial Operations and Business Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NGSX | BUY | 2008-11-25 | $3K | — | Filing → |
| NGSX | BUY | 2008-11-20 | $3K | — | Filing → |
| NGSX | BUY | 2008-11-14 | $5K | — | Filing → |